NASDAQ 100
29.064,90
PKT
-255,76
PKT
-0,87
%
Indikation*
29.064,80
PKT
-255,86
PKT
-0,87
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.06.12 | Microsoft buy | Nomura | |
| 04.06.12 | Alphabet A (ex Google) overweight | Barclays Capital | |
| 04.06.12 | Apple overweight | Piper Jaffray & Co. | |
| 04.06.12 | Meta Platforms (ex Facebook) outperform | Robert W. Baird & Co. Incorporated | |
| 01.06.12 | Meta Platforms (ex Facebook) outperform | Robert W. Baird & Co. Incorporated | |
| 31.05.12 | Meta Platforms (ex Facebook) halten | Der Aktionär | |
| 31.05.12 | Apple overweight | Barclays Capital | |
| 31.05.12 | Walmart overweight | Barclays Capital | |
| 31.05.12 | Microsoft buy | Citigroup Corp. | |
| 31.05.12 | QUALCOMM overweight | Piper Jaffray & Co. | |
| 30.05.12 | Costco Wholesale hold | McAdams Wright Ragen Inc. | |
| 30.05.12 | Cisco outperform | Oppenheimer & Co. Inc. | |
| 30.05.12 | Apple buy | Société Générale Group S.A. (SG) | |
| 30.05.12 | QUALCOMM sector outperform | Scotia Capital Markets | |
| 30.05.12 | Apple outperform | RBC Capital Markets | |
| 30.05.12 | Intel kaufen | Hamburger Sparkasse AG (Haspa) | |
| 30.05.12 | Biogen outperform | RBC Capital Markets | |
| 30.05.12 | Biogen neutral | JP Morgan Chase & Co. | |
| 29.05.12 | Linde buy | Deutsche Bank AG | |
| 29.05.12 | Microsoft buy | UBS AG | |
| 29.05.12 | QUALCOMM buy | UBS AG | |
| 29.05.12 | Apple overweight | Piper Jaffray & Co. | |
| 28.05.12 | Vertex Pharmaceuticals overweight | Barclays Capital | |
| 28.05.12 | Automatic Data Processing overweight | Barclays Capital | |
| 25.05.12 | Kraft Heinz Company sector perform | RBC Capital Markets | |
| 25.05.12 | NVIDIA outperform | RBC Capital Markets | |
| 25.05.12 | Kraft Heinz Company neutral | Sarasin Research | |
| 25.05.12 | Baker Hughes hold | Société Générale Group S.A. (SG) | |
| 25.05.12 | Gilead Sciences kaufen | Der Aktionär | |
| 24.05.12 | Analog Devices equal-weight | Barclays Capital | |
| 23.05.12 | QUALCOMM outperform | Oppenheimer & Co. Inc. | |
| 23.05.12 | Apple outperform | Oppenheimer & Co. Inc. | |
| 23.05.12 | Meta Platforms (ex Facebook) buy | Needham & Company, LLC | |
| 23.05.12 | NVIDIA outperform | RBC Capital Markets | |
| 23.05.12 | Intel outperform | RBC Capital Markets | |
| 23.05.12 | Analog Devices neutral | UBS AG | |
| 23.05.12 | Apple overweight | Barclays Capital | |
| 23.05.12 | Linde buy | Société Générale Group S.A. (SG) | |
| 22.05.12 | Walmart halten | Independent Research GmbH | |
| 22.05.12 | Cognizant overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.